What is the optimal validity period for a pre‑operative cardiac assessment in asymptomatic patients without known cardiovascular disease according to international cardiology societies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What preoperative management is recommended for a patient with a high Revised Cardiac Risk Index (RCRI)?

How do you assess and minimize perioperative cardiovascular morbidity and mortality in patients undergoing preanesthetic evaluation, considering factors such as age, gender, type of surgery, functional status, and comorbid conditions like hypertension, diabetes, and heart disease?

What is the recommended cardiac workup for a patient with known or suspected cardiovascular disease, hypertension, diabetes, or hyperlipidemia prior to surgery?

How long is a pre‑operative cardiac risk assessment valid?

How long does a pre‑operative cardiac risk assessment remain valid in a stable patient, and when should it be repeated?

Is fondaparinux appropriate for venous thromboembolism prophylaxis or treatment in a patient with moderate renal impairment (creatinine clearance 35 mL/min) and concern for heparin‑induced thrombocytopenia, who is not pregnant and has no active bleeding?

What are the clinical features, diagnostic work‑up, and management of laryngo‑onycho‑cutaneous syndrome (Shabir syndrome)?

Can amiodarone be started in a hypokalemic, NPO patient who is also receiving digoxin?

How should I adjust dosing and monitoring for a 14‑year‑old male with bipolar disorder, who has failed aripiprazole and lurasidone and is currently on paliperidone (Invega) 6 mg extended‑release daily, valproic acid 500 mg nightly (causing nausea and headache), and quetiapine (Seroquel) as needed for insomnia or agitation, to achieve therapeutic levels while minimizing side‑effects?

In a patient with recurrent venous thromboembolism despite a direct oral anticoagulant (DOAC) and therapeutic low‑molecular‑weight heparin (LMWH), who has Factor V Leiden thrombophilia and refuses warfarin, is fondaparinux an appropriate alternative?

What is the recommended first‑line management for acute otitis media in a patient nine months after tympanoplasty who still has a tympanostomy tube in place?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.